Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial evaluating IBI112 for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Effect of Long-term Psoriasis on Patients' Life - CORONATE
This clinical trial update from AbbVie reports the completion of CORONATE, a study on the long-term impact of psoriasis on patients' daily l…
-
EMA approval · 2024-10-24EMA Authorised: Jylamvo (methotrexate) — Oresund Pharma ApS
The European Medicines Agency authorised Jylamvo, a methotrexate product from Oresund Pharma ApS, for indications including psoriatic arthri…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients [Phase 4]
Phase 4 study evaluated the efficacy and tolerability of topical skincare products in patients with psoriasis, including plaque psoriasis, a…
-
FDA approval · 2024-10-23FDA Approved: JYLAMVO — Supplemental Application (SHORLA ONCOLOGY INC.)
The FDA approved a supplemental application for JYLAMVO (methotrexate) filed by SHORLA ONCOLOGY INC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis [Phase 2]
A Phase 2 study evaluating the efficacy and safety of ASP015K in adults with moderate to severe psoriasis has completed.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis [NA]
A clinical trial in psoriasis is examining how glucose metabolism affects the migration of cutaneous dendritic cells, with participant recru…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study) [NA]
A completed, multi-center randomized study from Novartis evaluating detection of psoriatic arthritis in Korean patients with moderate-to-sev…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Cardiovascular Risk Predictors in Patients With Psoriasis
This document reports the completion of a clinical trial evaluating cardiovascular risk predictors in patients with psoriasis, highlighting …
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of GM-XANTHO (GM-XAN003) for psoriasis is described, with status not yet recruit…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970 [Phase 1]
Phase 1 clinical trial evaluating single and multiple oral doses of GLPG3970 in healthy participants and in psoriasis patients has completed…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
This clinical trial update describes a study to identify cutaneous and blood biomarkers that predict response to systemic treatments across …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Light Treatment Effectiveness (LITE) Study [NA]
The Light Treatment Effectiveness (LITE) study, a completed clinical trial, has posted results evaluating light-based therapy for psoriasis …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial [Phase 1, Phase 2]
A clinical trial update describing a single-arm Phase 1/2 study evaluating an infliximab biosimilar for moderate to severe chronic plaque ps…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Meditation in Inflammatory Dermatosis [NA]
A clinical trial update indicates a sponsor in Paris is recruiting a study to evaluate meditation for inflammatory skin conditions, includin…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Dose Tapering Study of Adalimumab in Psoriasis [Phase 4]
A Phase 4 dose-tapering trial of adalimumab for psoriasis has been terminated. The study was sponsored by University Hospital Ghent.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients. [Phase 4]
Phase 4 trial evaluating therapeutic drug monitoring of secukinumab in psoriasis patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis [Phase 2]
Phase 2 trial evaluating VTX958 vs placebo for moderate to severe psoriasis was terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients [Phase 4]
Phase 4 clinical trial update on therapeutic drug monitoring of ixekizumab in patients with psoriasis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound? [NA]
This clinical trial investigated whether patients with skin psoriasis have subclinical features of active psoriatic arthritis detected by mu…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Modified Intermittent Fasting in Psoriasis [NA]
A completed clinical trial investigated modified intermittent fasting for psoriasis.
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: HPP737 Substance Balance Study in Human [NA]
Clinical trial update for a substance balance study of HPP737 in humans for psoriasis; the study has not yet begun recruiting.
-
CLINICAL_TRIALS other · 2024-09-04Clinical Trial Update: Cytokine Expression in Psoriasis Patients with and Without Joint Involvement [NA]
A clinical trial investigating cytokine expression in psoriasis patients with and without psoriatic arthritis, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis [Phase 1]
A Phase 1 study evaluating the safety and tolerability of ILV-094 in adults with psoriasis has completed, with results posted.
-
FDA approval · 2024-08-22FDA Approved: BETAMETHASONE VALERATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original ANDA for Betamethasone Valerate topical (Alembic Pharmaceuticals), a generic corticosteroid product for inflammator…